Literature DB >> 10583397

The antimicrobial peptide trichogin and its interaction with phospholipid membranes.

R F Epand1, R M Epand, V Monaco, S Stoia, F Formaggio, M Crisma, C Toniolo.   

Abstract

The interaction of the antimicrobial peptide trichogin GA IV with phospholipid bilayers has been studied. A series of analogs of trichogin was synthesized in which the nitroxide spin label, 4-amino-4-carboxy-2,2,6,6-tetramethylpiperidino-1-oxyl (TOAC), replaced one of the three alpha-aminoisobutyric acid (Aib) residues in the sequence. These modified peptides were used to assess the location of different residues of the peptide in a phospholipid bilayer composed of egg phosphatidylcholine containing 0.4 mol% of a fluorescently labelled phospholipid. We demonstrate that the substitution of Aib residues with TOAC does not alter the manner in which the peptide affects membrane curvature or induces vesicle leakage. The proximity of the nitroxide group on the peptide to the 4,4-difluoro-4-bora-3a,4a-diaza-S-indacene (BODIPY) fluorophore attached to the phospholipid was estimated from the extent of quenching of the fluorescence. By this criterion it was concluded that the peptide penetrates into the bilayer and that Aib4 is the most deeply inserted of the Aib residues. The results suggest that the helix axis of the peptide is oriented along the plane of the membrane. All of the peptides were shown to raise the bilayer to the hexagonal phase transition temperature of dipalmitoleoylphosphatidylethanolamine, indicating that they promote positive membrane curvature. This is a property observed with peptides that do not penetrate deeply into the bilayer or are oriented along the bilayer normal. We also demonstrate trichogin-promoted leakage of the aqueous contents of liposomes. These results indicate that the peptides cause bilayer destabilization. The extent of leakage induced by trichogin is very sensitive to the peptide to lipid ratio over a narrow range.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10583397     DOI: 10.1046/j.1432-1327.1999.00945.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

Review 1.  Antimicrobial peptides: current status and therapeutic potential.

Authors:  Andreas R Koczulla; Robert Bals
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  Location and aggregation of the spin-labeled peptide trichogin GA IV in a phospholipid membrane as revealed by pulsed EPR.

Authors:  E S Salnikov; D A Erilov; A D Milov; Yu D Tsvetkov; C Peggion; F Formaggio; C Toniolo; J Raap; S A Dzuba
Journal:  Biophys J       Date:  2006-06-02       Impact factor: 4.033

3.  Mechanism of membrane activity of the antibiotic trichogin GA IV: a two-state transition controlled by peptide concentration.

Authors:  Claudia Mazzuca; Lorenzo Stella; Mariano Venanzi; Fernando Formaggio; Claudio Toniolo; Basilio Pispisa
Journal:  Biophys J       Date:  2005-02-18       Impact factor: 4.033

4.  The zeamine antibiotics affect the integrity of bacterial membranes.

Authors:  Joleen Masschelein; Charlien Clauwers; Karen Stalmans; Koen Nuyts; Wim De Borggraeve; Yves Briers; Abram Aertsen; Chris W Michiels; Rob Lavigne
Journal:  Appl Environ Microbiol       Date:  2014-12-01       Impact factor: 4.792

5.  The activity of the amphipathic peptide delta-lysin correlates with phospholipid acyl chain structure and bilayer elastic properties.

Authors:  Antje Pokorny; Erin M Kilelee; Diana Wu; Paulo F F Almeida
Journal:  Biophys J       Date:  2008-08-15       Impact factor: 4.033

Review 6.  On the role of NMR spectroscopy for characterization of antimicrobial peptides.

Authors:  Fernando Porcelli; Ayyalusamy Ramamoorthy; George Barany; Gianluigi Veglia
Journal:  Methods Mol Biol       Date:  2013

7.  The spin label amino acid TOAC and its uses in studies of peptides: chemical, physicochemical, spectroscopic, and conformational aspects.

Authors:  Shirley Schreier; José Carlos Bozelli; Nélida Marín; Renata F F Vieira; Clóvis R Nakaie
Journal:  Biophys Rev       Date:  2012-01-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.